Milestone Pharmaceuticals Inc. Peo Total Comp Amt
Milestone Pharmaceuticals Inc. (MIST) reported Peo Total Comp Amt of $2.12 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-30.
Financial Statements › Notes
ecd:PeoTotalCompAmt · last filed 2026-04-30
| Period end | Peo Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $2.12M DEF 14A · filed 2026-04-30 |
| 2024-12-31 | $854.27K DEF 14A · filed 2026-04-30 |
| 2023-12-31 | $1.98M DEF 14A · filed 2026-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |